News und Analysen

The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 38 years, today announced the details of its 2020 Community Partners Program. Through this initiative, The Humana

Veeva Systems (NYSE:VEEV) today introduced Veeva Vault Payments, a new add-on application for Veeva Vault CTMS that manages the payment and reimbursement process to clinical research sites. Vault

Veeva Systems (NYSE:VEEV) today announced the availability of Veeva SiteVault Free, a free eRegulatory solution for clinical research sites. Veeva SiteVault replaces manual and paper-based

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 38^th Annual J.P. Morgan

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 38^th annual J.P. Morgan Healthcare

Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on

Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can

Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.

Cell

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invite investors to participate via webcast.

J.P. Morgan Healthcare

Agilent Technologies Inc. (NYSE: A) today announced the following presentation will be webcast for the investor community:

What: 38th Annual J.P. Morgan Healthcare Conference

Where: The Westin

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the Company’s supplemental New Drug Application (sNDA) for

Pfizer Inc. (NYSE: PFE) and Mylan N.V. (NASDAQ: MYL) today announced that Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned combination of Mylan N.V

As part of the company’s efforts to improve the health and well-being of the communities it serves, Humana announced today that Atlanta, Charlotte and Houston are now Bold Goal communities

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 28, 2020. The

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) has approved a

Pfizer Inc. (NYSE: PFE) announced today that its board of directors declared a 38-cent per share first-quarter 2020 dividend on the company’s common stock, payable March 6, 2020 to holders of the

Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved XELJANZ^® XR (tofacitinib) extended-release 11 mg and 22 mg tablets for the once-daily treatment

Leading health and well-being company Humana Inc. (NYSE: HUM) is expanding its care management portfolio by teaming up with two specialized care management companies to offer personalized

Waters Corporation (NYSE:WAT) today announced its 2025 sustainability goals and simultaneously announced a commitment to report its sustainability progress annually. These goals were developed

Agilent Technologies, Inc. (NYSE: A) today announced it has been selected as one of the top four “Best Workplaces™ in Greater China” by the Great Place to Work® (GPTW) Institute. The company has